Get an alert when CHUGAI PHARMA U.K. LTD. files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-05-13 (in 1y)

Last made up 2026-04-29

Watchouts

None on the register

Cash

£27M

+7.7% vs 2023

Net assets

£30M

+3.7% vs 2023

Employees

24

-20% vs 2023

Profit before tax

£2M

+167.5% vs 2023

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £8,653,316£9,427,882
Operating profit -£87,877£883,418
Profit before tax £722,093£1,931,694
Net profit £549,049£1,446,343
Cash £25,356,161£27,301,911
Total assets less current liabilities £28,600,066£29,659,855
Net assets £28,597,846£29,659,855
Equity £28,597,846£29,659,855
Average employees 3024
Wages £2,847,290£2,416,377

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin -1.0%9.4%
Net margin 6.3%15.3%
Return on capital employed -0.3%3.0%
Gearing (liabilities / total assets) 9.0%6.6%
Current ratio 11.05x15.11x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101 Reduced Disclosure Framework
Reporting scope
Standalone (parent only)
Auditor
KPMG LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors are satisfied that the Company has adequate resources to continue to operate for a period not less than 12 months from the date of approval of the financial statements and that there are no material uncertainties around their assessment. Accordingly, the Directors continue to adopt the going concern basis of accounting.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 46 resigned

Name Role Appointed Born Nationality
UEMATSU, Yuta Secretary 2025-01-01
CROSHER, Mike Director 2019-10-01 Mar 1977 British
HENRIOT, Nicolas Jacques Andre Director 2025-01-01 Aug 1969 French
OKAMOTO, Takashi Director 2025-01-01 Aug 1973 Japanese
Show 46 resigned officers
Name Role Appointed Resigned
FURUKAWA, Tetsuo Secretary 2012-10-01 2015-10-01
HALLS, John Leslie Seaton Secretary 1996-09-30 1999-01-01
HIBINO, Yoshinori Secretary 1993-05-05 1994-05-11
ISHIMURA, Ryo Secretary 2024-01-01 2024-12-31
LAYBOURN, Felicity Anne Secretary 1993-05-04 1993-05-05
MCGOWAN, Zoe Secretary 2018-07-01 2019-10-01
NISHIMURA, Kimio Secretary 1999-01-01 2001-10-04
ROBINSON, Troy Joseph Secretary 2018-04-01 2018-06-30
SAITO, Yoshimasa Secretary 2003-01-01 2010-07-01
TAKE, Ryojun Secretary 2001-10-04 2003-01-01
TATEMATSU, Naoki Secretary 2019-10-01 2020-04-01
TATEMATSU, Naoki Secretary 2015-10-01 2018-04-01
TERADA, Mitsuhiro Secretary 2020-04-01 2021-12-31
UCHIKURA, Yoshiki Secretary 1994-05-11 1996-09-30
UEMATSU, Yuta Secretary 2022-01-01 2024-01-01
USUDA, Masashi Secretary 2010-07-01 2012-10-01
ANDO, Nobuyoshi Director 1995-05-01 1999-12-01
ASANO, Katsuaki Director 1993-05-05 1996-06-27
CURRIE, Ruth Ann Director 2013-01-01 2018-06-30
HALLS, John Leslie Seaton Director 1996-09-30 2019-10-01
HIBINO, Yoshinori Director 1996-06-27 2006-03-22
HIBINO, Yoshinori Director 1993-05-05 1995-05-01
HILLHOUSE, Robert James Director 1993-05-04 1993-05-05
IZUMOTO, Hiroshi Director 2001-11-26 2005-01-01
KATO, Susumu Director 2016-04-01 2018-04-01
KISHI, Kentaro Director 2023-01-01 2024-12-31
KONO, Keiji Director 2012-04-02 2013-01-01
MORITA, Koichi Director 1994-06-11 1995-05-01
NAKAMURA, Naotaka Director 2007-12-12 2012-04-02
NAKAMURA, Naotaka Director 1999-12-01 2003-01-01
NISHIKAWA, Koichi Director 2005-01-01 2019-10-01
OGASAWARA, Tsuguo Director 1996-06-27 2002-06-27
OKAMOTO, Takashi Director 2021-01-01 2023-01-01
ONOZAWA, Norihisa Director 2019-10-01 2021-01-01
ROBINSON, Troy Joseph Director 2018-07-01 2024-12-31
SAITO, Masataka Director 1999-12-01 2003-01-01
SAITO, Yoshimasa Director 2010-07-01 2013-10-01
SHIMADA, Tatsuji Director 2006-03-23 2010-07-01
SUZUKI, Motomu Director 1995-05-01 1995-06-27
TATEMATSU, Naoki Director 2013-10-01 2015-10-01
TOHAYA, Masaaki Director 2013-01-01 2016-04-01
UCHIKURA, Yoshiki Director 1998-01-01 2007-12-12
UCHIKURA, Yoshiki Director 1994-05-11 1996-09-30
UENO, Motoo Director 1993-05-05 1998-01-01
UNNO, Masaharu Director 1998-01-01 1999-11-30
YOSHIDA, Takeshi Director 1993-05-05 1994-05-11

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Chugai Pharma Europe Ltd Corporate entity Shares 75–100% 2016-04-06 Active

Filing timeline

Last 20 of 187 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2022-07-06 CC04 Statement of companys objects
Date Type Category Description
2026-05-06 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-12-23 AD01 address Change registered office address company with date old address new address PDF
2025-09-24 AA accounts Accounts with accounts type full
2025-05-12 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-01-02 AP03 officers Appoint person secretary company with name date PDF
2025-01-02 AP01 officers Appoint person director company with name date PDF
2025-01-02 AP01 officers Appoint person director company with name date PDF
2025-01-02 TM02 officers Termination secretary company with name termination date PDF
2025-01-02 TM01 officers Termination director company with name termination date PDF
2025-01-02 TM01 officers Termination director company with name termination date PDF
2024-09-28 AA accounts Accounts with accounts type full
2024-04-29 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-01-03 AP03 officers Appoint person secretary company with name date PDF
2024-01-03 TM02 officers Termination secretary company with name termination date PDF
2023-09-26 AA accounts Accounts with accounts type full
2023-05-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-01-03 AP01 officers Appoint person director company with name date PDF
2023-01-03 TM01 officers Termination director company with name termination date PDF
2022-09-24 AA accounts Accounts with accounts type full
2022-07-06 CC04 change-of-constitution Statement of companys objects

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page